Novel Technologies for Vaccine Development

Novel Technologies for Vaccine Development

Paperback(Softcover reprint of the original 1st ed. 2014)

$169.99
View All Available Formats & Editions
Use Express Shipping for guaranteed delivery by December 24 
Qualifying orders placed by 11:59 a.m. ET on Dec. 21 can still be sent to Manhattan, NY addresses. Details

Product Details

ISBN-13: 9783709119808
Publisher: Springer Vienna
Publication date: 08/31/2016
Edition description: Softcover reprint of the original 1st ed. 2014
Pages: 386
Product dimensions: 6.10(w) x 9.25(h) x (d)

Table of Contents

Reverse Genetics Approaches for Rational Design of Inactivated and Live-Attenuated Influenza Vaccines.- Viral-Vectored Vaccines to Control Pathogenic Filoviruses.- Alphavirus Replicon Vectors for Prophylactic Applications and Cancer Intervention.- Current Status and Future of Polio Vaccines and Vaccination.- Current Status of Hantavirus Vaccines Development.- Experimental DNA-Launched Live Attenuated Vaccines against Infections Caused by Flavi- and Alphaviruses.- Sugar-Based Immune Adjuvants for Use in Recombinant, Viral, Vector, DNA and Other Styles of Vaccines.- Adenovirus-based Vectors for the Development of Prophylactic and Therapeutic Vaccines.- Radiovirotherapy for the Treatment of Cancer.- TRICOM Poxviral-Based Vaccines for the Treatment of Cancer.- The Use of Oncolytic Herpesvirus for the Treatment of Cancer.- SA-4-1BBL; A Novel form of the 4-1BB Costimulatory Ligand as an Adjuvant Platform for the Development of Subunit Cancer Vaccines.

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews